# SPEARHEAD-3 Pediatric Study

> **NCT05642455** · PHASE1,PHASE2 · RECRUITING · sponsor: **USWM CT, LLC** · enrollment: 20 (estimated)

## Conditions studied

- Synovial Sarcoma
- Malignant Peripheral Nerve Sheath Tumor (MPNST)
- Neuroblastoma (NBL)
- Osteosarcoma

## Interventions

- **GENETIC:** Afamitresgene autoleucel

## Key facts

- **NCT ID:** NCT05642455
- **Lead sponsor:** USWM CT, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2026-10-01
- **Final completion:** 2038-07-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05642455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05642455, "SPEARHEAD-3 Pediatric Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05642455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*